Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Cancer J. 2010 Jul–Aug;16(4):374–381. doi: 10.1097/PPO.0b013e3181eb33a6

Table 1.

SYSTEM SOURCE ANTIGEN DEPENDENT OR INDEPENDENT AMENABLE TO TRANSDUCTION ANTIGEN PROCESSING CLINICAL TRIALS COMMENTS
Cellular
K562 Human erythroleukemia Both Yes Yes No Transduced Fc receptors can bind αCD3 or HLA-Ig to allow antigen-specific or non-specific CD8+ T cell expansion
Better CD8+ T cell proliferation when expressing 4-1BBL than αCD28
Has been prepared as GMP-compliant stock
Might require HLA transduction for antigen presentation
3T3 Murine fibroblast Both Yes Yes No Minimal evidence of xenoreactivity
Requires HLA transduction for antigen presentation
Insect Drosophila Schneider S2 cell line Both Yes No Yes Lysed at 37°C
Exogenous antigen only
Minimal evidence of xenoreactivity
Acellular
αCD3/αCD28 beads Synthetic Independent No No Yes Standardized manufacture
Excellent control of delivered signals
Better CD8+ T cell proliferation when 4-1BBL is substituted for αCD28
Can substitute or add costimulatory or inhibitory molecules
HLA-Ig beads Synthetic Dependent No No No Excellent control of delivered signals
Can substitute other HLA-Ig
Exogenous antigen loading only